{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:43:47Z","timestamp":1790534627712,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sygesikring Danmark","award":["2020-0178"],"award-info":[{"award-number":["2020-0178"]}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"crossref","award":["NNF14CC0001"],"award-info":[{"award-number":["NNF14CC0001"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"crossref","award":["NNF17OC0027594"],"award-info":[{"award-number":["NNF17OC0027594"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"crossref","award":["Denmark"],"award-info":[{"award-number":["Denmark"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Rigshospitalet's Foundation"},{"name":"Independent Research Fund Denmark","award":["0216-00014B"],"award-info":[{"award-number":["0216-00014B"]}]},{"DOI":"10.13039\/100008594","name":"European Hematology Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Independent Research Fund","award":["Denmark"],"award-info":[{"award-number":["Denmark"]}]},{"name":"Kirsten and Freddy Johansen\u2019s Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a \u201clong COVID\u201d syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants received a digital questionnaire on demographics and COVID-19-related symptoms. Persistent symptoms: symptoms &gt;\u20094\u00a0weeks (in sensitivity analyses &gt;\u200912\u00a0weeks). We included 445 participants, of whom 34% were asymptomatic. Most common acute symptoms were fatigue, headache, and sneezing, while fatigue and reduced smell and taste were most severe. Persistent symptoms, most commonly fatigue and memory and concentration difficulties, were reported by 36% of 198 symptomatic participants with follow-up &gt;\u20094\u00a0weeks. Risk factors for persistent symptoms included female sex (women 44% vs. men 24%, odds ratio 2.7, 95% CI 1.4\u20135.1, p\u2009=\u20090.003) and BMI (odds ratio 1.1, 95% CI 1.0\u20131.2, p\u2009=\u20090.001). In conclusion, among non-hospitalized PCR-confirmed COVID-19 patients one third were asymptomatic while one third of symptomatic participants had persistent symptoms illustrating the heterogeneity of disease presentation. These findings should be considered in health care planning and policy making related to COVID-19.<\/jats:p>","DOI":"10.1038\/s41598-021-92045-x","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T06:05:05Z","timestamp":1624428305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":168,"title":["Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients"],"prefix":"10.1038","volume":"11","author":[{"given":"Sofie","family":"Bliddal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Banasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole Birger","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janna","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Cantwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schwinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Tulstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Westergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Ullum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Brunak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Tommerup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjarke","family":"Feenstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisse Rye","family":"Ostrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Gr\u00f8nb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus Henrik","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne Dam","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Feldt-Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,23]]},"reference":[{"key":"92045_CR1","unstructured":"Johns Hopkins University. The Johns Hopkins Coronavirus Resource Center. https:\/\/coronavirus.jhu.edu\/map.html. (2021)."},{"key":"92045_CR2","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu, Z. & McGoogan, J. M. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323, 1239\u20131242 (2020).","journal-title":"JAMA"},{"key":"92045_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"92045_CR4","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1016\/j.jinf.2020.04.021","volume":"81","author":"Z Zheng","year":"2020","unstructured":"Zheng, Z. et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J. Infect. 81, e16\u2013e25 (2020).","journal-title":"J. Infect."},{"key":"92045_CR5","doi-asserted-by":"publisher","first-page":"e0234765","DOI":"10.1371\/journal.pone.0234765","volume":"15","author":"MC Grant","year":"2020","unstructured":"Grant, M. C. et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS ONE 15, e0234765 (2020).","journal-title":"PLoS ONE"},{"key":"92045_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ijid.2020.06.052","volume":"98","author":"A Kronbichler","year":"2020","unstructured":"Kronbichler, A. et al. Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis. Int. J. Infect. Dis. 98, 180\u2013186 (2020).","journal-title":"Int. J. Infect. Dis."},{"key":"92045_CR7","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1056\/NEJMoa2008457","volume":"382","author":"MM Arons","year":"2020","unstructured":"Arons, M. M. et al. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N. Engl. J. Med. 382, 2081\u20132090 (2020).","journal-title":"N. Engl. J. Med."},{"key":"92045_CR8","doi-asserted-by":"publisher","first-page":"m3001","DOI":"10.1136\/bmj.m3001","volume":"370","author":"E Fraser","year":"2020","unstructured":"Fraser, E. Long term respiratory complications of COVID-19. BMJ 370, m3001 (2020).","journal-title":"BMJ"},{"key":"92045_CR9","doi-asserted-by":"publisher","first-page":"e0240784","DOI":"10.1371\/journal.pone.0240784","volume":"15","author":"L Townsend","year":"2020","unstructured":"Townsend, L. et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE 15, e0240784 (2020).","journal-title":"PLoS ONE"},{"key":"92045_CR10","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin20.544","author":"C Hopkins","year":"2020","unstructured":"Hopkins, C. et al. Six month follow-up of self-reported loss of smell during the COVID-19 pandemic. Rhinology https:\/\/doi.org\/10.4193\/Rhin20.544 (2020).","journal-title":"Rhinology"},{"key":"92045_CR11","unstructured":"Fjaeldstad, A. W. Prolonged complaints of chemosensory loss after COVID-19. Dan. Med. J. 67, A05200340 (2020)."},{"key":"92045_CR12","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jama.2020.12603","volume":"324","author":"A Carfi","year":"2020","unstructured":"Carfi, A., Bernabei, R. & Landi, F. Persistent symptoms in patients after acute COVID-19. JAMA 324, 603\u2013605 (2020).","journal-title":"JAMA"},{"key":"92045_CR13","doi-asserted-by":"publisher","first-page":"e0243882","DOI":"10.1371\/journal.pone.0243882","volume":"15","author":"LG Jacobs","year":"2020","unstructured":"Jacobs, L. G. et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS ONE 15, e0243882 (2020).","journal-title":"PLoS ONE"},{"key":"92045_CR14","doi-asserted-by":"crossref","unstructured":"Huang, C. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 397, 220\u2013232 (2021).","DOI":"10.1016\/S0140-6736(20)32656-8"},{"key":"92045_CR15","unstructured":"PHOSP-COVID consortium & Leicester University. The Post-hospitalisation COVID-19 study (PHOSP-COVID). https:\/\/www.phosp.org\/. 2020)."},{"key":"92045_CR16","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/S0140-6736(20)32662-3","volume":"396","author":"The Lancet","year":"2020","unstructured":"The Lancet. Facing up to long COVID. Lancet 396, 1861 (2020).","journal-title":"Lancet"},{"key":"92045_CR17","doi-asserted-by":"crossref","unstructured":"Navabi. Long covid: How to define it and how to manage it. BMJ. 370, m3489 (2020).","DOI":"10.1136\/bmj.m3489"},{"key":"92045_CR18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/d41586-020-02796-2","volume":"586","author":"Nature","year":"2020","unstructured":"Nature. Long COVID: Let patients help define long-lasting COVID symptoms. Nature 586, 170 (2020).","journal-title":"Nature"},{"key":"92045_CR19","unstructured":"National Institute for Health and Care Excellence. COVID-19 rapid guideline: Managing the long-term effects of COVID-19. https:\/\/www.nice.org.uk\/guidance\/ng188\/chapter\/1-Identifying-people-with-ongoing-symptomatic-COVID-19-or-post-COVID-19-syndrome. (2020)."},{"key":"92045_CR20","doi-asserted-by":"crossref","unstructured":"Meys, R. et al. Generic and Respiratory-Specific Quality of Life in Non-Hospitalized Patients with COVID-19. J. Clin. Med. 9, (2020).","DOI":"10.3390\/jcm9123993"},{"key":"92045_CR21","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1186\/s12913-020-06001-y","volume":"20","author":"E Ladds","year":"2020","unstructured":"Ladds, E. et al. Persistent symptoms after COVID-19: Qualitative study of 114 \u201clong COVID\u201d patients and draft quality principles for services. BMC. Health Serv. Res. 20, 1144 (2020).","journal-title":"BMC. Health Serv. Res."},{"key":"92045_CR22","unstructured":"The Danish Digitization Agency. Statistics on Digital Post. https:\/\/digst.dk\/it-loesninger\/digital-post\/om-loesningen\/tal-og-statistik-om-digital-post\/. (2020)."},{"key":"92045_CR23","doi-asserted-by":"crossref","unstructured":"Voldstedlund, M., Haarh, M., & Molbak, K. MiBa Board of Representatives. Euro. Surveill. 19, 20667 (2014).","DOI":"10.2807\/1560-7917.ES2014.19.1.20667"},{"key":"92045_CR24","unstructured":"Statens Serum Institut. The Danish National Biobank. https:\/\/www.danishnationalbiobank.com\/. (2021). (Accessed 22 Dec 2020)"},{"key":"92045_CR25","unstructured":"Statens Serum Institut. The Danish National Biobank. https:\/\/www.danishnationalbiobank.com\/. (2020)."},{"key":"92045_CR26","unstructured":"The Capital Region of Denmark. The Copenhagen Hospital Biobank. https:\/\/www.regionh.dk\/forskning-og-innovation\/Region-Hovedstadens-biobank\/Sider\/default.aspx. (2020). (Accessed 22 Dec 2020)"},{"key":"92045_CR27","unstructured":"Pedersen, O. B. et al. SARS-CoV-2 infection fatality rate among elderly retired Danish blood donors\u2014A cross-sectional study. Clin. Infect. Dis. 26, ciaa1627 (2020)."},{"key":"92045_CR28","unstructured":"Statens Serum Institut. Influmeter. https:\/\/www.ssi.dk\/aktuelt\/nyheder\/2020\/vil-du-hjaelpe-statens-serum-institut-med-at-overvaage-influenza-og-covid19. (2020). (Accessed 10 May 2021)"},{"key":"92045_CR29","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.R-project.org\/. (2021)."},{"key":"92045_CR30","doi-asserted-by":"crossref","unstructured":"Davis, H. E. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. https:\/\/www.medrxiv.org\/content\/10.1101\/2020.12.24.20248802v2. (2021).","DOI":"10.1101\/2020.12.24.20248802"},{"key":"92045_CR31","unstructured":"van den Borst, B. et al. Comprehensive health assessment three months after recovery from acute COVID-19. Clin. Infect. Dis., ciaa1750 (2020)."},{"key":"92045_CR32","doi-asserted-by":"publisher","unstructured":"Mandal, S. et al. 'Long-COVID': A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. https:\/\/doi.org\/10.1136\/thoraxjnl-2020-215818 (2020).","DOI":"10.1136\/thoraxjnl-2020-215818"},{"key":"92045_CR33","doi-asserted-by":"publisher","first-page":"993","DOI":"10.15585\/mmwr.mm6930e1","volume":"69","author":"MW Tenforde","year":"2020","unstructured":"Tenforde, M. W. et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate Health Care Systems Network\u2014United States, March\u2013June 2020. MMWR Morb. Mortal. Wkly. Rep. 69, 993\u2013998 (2020).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"92045_CR34","doi-asserted-by":"publisher","unstructured":"Petersen, M. S. et al. Long COVID in the Faroe Islands\u2014a longitudinal study among non-hospitalized patients. Clin. Infect. Dis., ciaa1792, https:\/\/doi.org\/10.1093\/cid\/ciaa1792 (2020).","DOI":"10.1093\/cid\/ciaa1792"},{"key":"92045_CR35","doi-asserted-by":"crossref","unstructured":"Cirulli, E. T. et al. Long-term COVID-19 symptoms in a large unselected population. https:\/\/www.medrxiv.org\/content\/10.1101\/2020.10.07.20208702v3. (2021).","DOI":"10.1101\/2020.10.07.20208702"},{"key":"92045_CR36","doi-asserted-by":"crossref","unstructured":"Sudre, C. H. et al. Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. https:\/\/www.medrxiv.org\/content\/10.1101\/2020.10.19.20214494v2. (2021).","DOI":"10.1101\/2020.10.19.20214494"},{"key":"92045_CR37","unstructured":"Patient-Led Research for COVID-19. Report: What does COVID-19 recovery actually look like? https:\/\/patientresearchcovid19.com\/research\/report-1\/. (2021)."},{"key":"92045_CR38","doi-asserted-by":"crossref","unstructured":"Goertz, Y. M. J. et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ. Open. Res. 6, 00542 (2020).","DOI":"10.1183\/23120541.00542-2020"},{"key":"92045_CR39","doi-asserted-by":"crossref","unstructured":"Walsh-Messinger, J. et al. The Kids Are Not Alright: A Preliminary Report of Post-COVID Syndrome in University Students. https:\/\/www.medrxiv.org\/content\/10.1101\/2020.11.24.20238261v2.full.pdf. (2021).","DOI":"10.1101\/2020.11.24.20238261"},{"key":"92045_CR40","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/s41591-020-01177-6","volume":"26","author":"Nature Medicine","year":"2020","unstructured":"Nature Medicine. Meeting the challenge of long COVID. Nat. Med. 26, 1803 (2020).","journal-title":"Nat. Med."},{"key":"92045_CR41","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1046\/j.1525-1497.1997.00074.x","volume":"12","author":"JP Metlay","year":"1997","unstructured":"Metlay, J. P. et al. Measuring symptomatic and functional recovery in patients with community-acquired pneumonia. J. Gen. Intern. Med. 12, 423\u2013430 (1997).","journal-title":"J. Gen. Intern. Med."},{"key":"92045_CR42","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1001\/archinternmed.2009.384","volume":"169","author":"MH Lam","year":"2009","unstructured":"Lam, M. H. et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: Long-term follow-up. Arch. Intern. Med. 169, 2142\u20132147 (2009).","journal-title":"Arch. Intern. Med."},{"key":"92045_CR43","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1001\/archinte.167.12.1312","volume":"167","author":"CM Tansey","year":"2007","unstructured":"Tansey, C. M. et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch. Intern. Med. 167, 1312\u20131320 (2007).","journal-title":"Arch. Intern. Med."},{"key":"92045_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/BOR.0000000000000564","volume":"31","author":"AC Billi","year":"2019","unstructured":"Billi, A. C., Kahlenberg, J. M. & Gudjonsson, J. E. Sex bias in autoimmunity. Curr. Opin. Rheumatol. 31, 53\u201361 (2019).","journal-title":"Curr. Opin. Rheumatol."},{"key":"92045_CR45","doi-asserted-by":"publisher","first-page":"m4774","DOI":"10.1136\/bmj.m4774","volume":"371","author":"L Turner-Stokes","year":"2020","unstructured":"Turner-Stokes, L. & Wade, D. T. Updated NICE guidance on chronic fatigue syndrome. BMJ 371, m4774 (2020).","journal-title":"BMJ"},{"key":"92045_CR46","first-page":"CD003200","volume":"10","author":"L Larun","year":"2019","unstructured":"Larun, L., Brurberg, K. G., Odgaard-Jensen, J. & Price, J. R. Exercise therapy for chronic fatigue syndrome. Cochrane. Database. Syst. Rev. 10, CD003200 (2019).","journal-title":"Cochrane. Database. Syst. Rev."},{"key":"92045_CR47","doi-asserted-by":"crossref","unstructured":"Vink, M. & Vink-Niese, A. Could cognitive behavioural therapy be an effective treatment for long COVID and post COVID-19 fatigue syndrome? Lessons from the Qure Study for Q-Fever Fatigue Syndrome. Healthcare. (Basel). 8, 552 2020).","DOI":"10.3390\/healthcare8040552"},{"key":"92045_CR48","unstructured":"World Health Organization. Support for Rehabilitation: Self-Management after COVID-19 Related Illness. https:\/\/www.who.int\/publications\/m\/item\/support-for-rehabilitation-self-management-after-covid-19-related-illness. (2020)."},{"key":"92045_CR49","doi-asserted-by":"publisher","first-page":"m3026","DOI":"10.1136\/bmj.m3026","volume":"370","author":"T Greenhalgh","year":"2020","unstructured":"Greenhalgh, T., Knight, M., A\u2019Court, C., Buxton, M. & Husain, L. Management of post-acute COVID-19 in primary care. BMJ 370, m3026 (2020).","journal-title":"BMJ"},{"key":"92045_CR50","doi-asserted-by":"crossref","unstructured":"Gorna, R. et al. Long COVID guidelines need to reflect lived experience. Lancet. 397, 455\u2013457(2020).","DOI":"10.1016\/S0140-6736(20)32705-7"},{"key":"92045_CR51","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1126\/science.abc0473","volume":"368","author":"DA Drew","year":"2020","unstructured":"Drew, D. A. et al. Rapid implementation of mobile technology for real-time epidemiology of COVID-19. Science 368, 1362\u20131367 (2020).","journal-title":"Science"},{"key":"92045_CR52","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/S1473-3099(20)30589-2","volume":"20","author":"K Iversen","year":"2020","unstructured":"Iversen, K. et al. Risk of COVID-19 in health-care workers in Denmark: An observational cohort study. Lancet Infect. Dis. 20, 1401\u20131408 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"92045_CR53","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1056\/NEJMoa2006100","volume":"382","author":"DF Gudbjartsson","year":"2020","unstructured":"Gudbjartsson, D. F. et al. Spread of SARS-CoV-2 in the Icelandic Population. N. Engl. J. Med. 382, 2302\u20132315 (2020).","journal-title":"N. Engl. J. Med."},{"key":"92045_CR54","doi-asserted-by":"publisher","first-page":"e2035057","DOI":"10.1001\/jamanetworkopen.2020.35057","volume":"4","author":"MA Johansson","year":"2021","unstructured":"Johansson, M. A. et al. SARS-CoV-2 transmission from people without COVID-19 symptoms. JAMA Netw. Open. 4, e2035057 (2021).","journal-title":"JAMA Netw. Open."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92045-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92045-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92045-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T05:12:11Z","timestamp":1670044331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92045-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,23]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["92045"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-92045-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.01.22.21249945","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,23]]},"assertion":[{"value":"19 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13153"}}